A cell model for the initial phase of sporadic Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 42, Issue 2, 2014, Pages 395-411

  Stockburger, Carola ^a   Gold, Vicki A M ^b   Pallas, Thea ^a   Kolesova, Natalie ^a   Miano, Davide ^a   Leuner, Kristina ^c   Müller, Walter E ^a  

^a GOETHE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aging; Alzheimer's disease; amyloid ; mitochondrial dynamics; mitochondrial function

Indexed keywords

AMYLOID PRECURSOR PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; TUBULIN; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CYTOCHROME C OXIDASE;

ALZHEIMER DISEASE; ARTICLE; CELL LOSS; CELL SWELLING; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME INHIBITION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NERVE FIBER GROWTH; NEURITE; OXIDATIVE STRESS; PROTEIN EXPRESSION; BIOLOGICAL MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE, TUMOR; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; NEUROBLASTOMA; TRANSFECTION;

EID: 84916892303     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140381     Document Type: Article

References (70)

1. Chen Z, Zhong C (2013) Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies. Prog Neurobiol 108, 21-43.
2. Swerdlow RH (2011) Brain aging, Alzheimer's disease, and mitochondria. Biochim Biophys Acta 1812, 1630-1639.
3. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I,Keil U, Strosznajder JB, Eckert A, Muller WE (2007) Mitochondrial dysfunction: The first domino in brain aging and Alzheimer's disease? Antioxid. Redox Signal 9, 1659-1675.
4. Müller WE, Eckert A, Kurz C, Eckert GP, Leuner K (2010) Mitochondrial dysfunction: Common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol Neurobiol 41, 159-171.
5. Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14, 45-53.
6. Eckert GP, Renner K, Eckert SH, Eckmann J, Hagl S, Abdel-Kader RM, Kurz C, Leuner K, Muller WE (2012) Mitochondrial dysfunction-a pharmacological target in Alzheimer's disease. Mol Neurobiol 46, 136-150.
7. Rhein V, Baysang G, Rao S, Meier F, Bonert A,Müller-Spahn F, Eckert A (2009) Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 29, 1063-1071.
8. Keil U, Scherping I, Hauptmann S, Schuessel K, Eckert A, Müller WE (2006) Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol 147, 199-208.
9. BrandMD,NichollsDG(2011) Assessing mitochondrial dysfunction in cells. Biochem J 435, 297-312.
10. Stadlmann S, Renner K, Pollheimer J, Moser PL, Zeimet AG, Offner FA, Gnaiger E (2006) Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1beta-treated human peritoneal mesothelial cells. Cell Biochem Biophys 44, 179-186.
11. Eckert SH, Eckmann J, Renner K, Eckert GP, Leuner K, Muller WE (2012) Dimebon ameliorates amyloid-beta induced impairments of mitochondrial form and function. J Alzheimers Dis 31, 21-32.
12. Karbowski M, Arnoult D, Chen H, Chan DC, Smith CL,Youle RJ (2004) Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 164, 493-499.
13. Hansson MJ, PerssonT, FribergH,KeepMF, Rees A,Wieloch T, ElmérE(2003) Powerful cyclosporin inhibition of calciuminduced permeability transition in brain mitochondria. Brain Res 960, 99-111.
14. Sims NR, Anderson MF (2008) Isolation of mitochondria from rat brain using Percoll density gradient centrifugation. Nat Protoc 3, 1228-1239.
15. Swerdlow RH, Burns JM, Khan SM (2010) The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 20(Suppl 2), S265-S279.
16. Leuner K, Schütt T,Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, Palmiter RD, Brandt U, Dröse S,Wittig I,Willem M, Haass C, Reichert AS, Müller WE (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 16, 1421-1433.
17. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Müller-Spahn F, Haass C, Czech C, Pradier L,Müller WE, EckertA(2004) Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279, 50310-50320.
18. Hedskog L, Zhang S, Ankarcrona M (2012) Strategic role for mitochondria in Alzheimer's disease and cancer. Antioxid Redox Signal 16, 1476-1491.
19. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39, 43-56.
20. Newington JT, Pitts A, Chien A, Arseneault R, Schubert D, Cumming RC (2011) Amyloid beta resistance in nerve cell lines is mediated by theWarburg effect. PLoS One 6, e19191.
21. Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, Morris JC, Raichle ME, Mintun MA (2010) Spatial correlation between brain aerobic glycolysis and amyloid- (A) deposition. Proc Natl Acad Sci U S A 107, 17763-17767.
22. Schmidt MM, Dringen R (2009) Differential effects of iodoacetamide and iodoacetate on glycolysis and glutathione metabolism of cultured astrocytes. Front Neuroenergetics 1, 1.
23. Chan DC (2012) Fusion and fission: Interlinked processes critical for mitochondrial health. Annu Rev Genet 46, 265-287.
24. Twig G, Elorza A, Molina AJA, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27, 433-446.
25. Davies KM, Strauss M, Daum B, Kief JH, Osiewacz HD, Rycovska A, Zickermann V, Kühlbrandt W (2011) Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc Natl Acad Sci U S A 108, 14121-14126.
26. Cha M-Y, Han S-H, Son SM, Hong H-S, Choi Y-J, Byun J, Mook-Jung I (2012) Mitochondria-specific accumulation of amyloid induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 7, e34929.
27. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH (2010) Mitochondria-targeted antioxidants protect against amyloidbeta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 20(Suppl 2), S609-S631.
28. Baloyannis SJ, Costa V, Michmizos D (2004) Mitochondrial alterations in Alzheimer's disease.AmJ Alzheimers Dis Other Demen 19, 89-93.
29. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344.
30. Mattson MP (2007) Mitochondrial regulation of neuronal plasticity. Neurochem Res 32, 707-715.
31. Kurz C, Ungerer I, Lipka U, Kirr S, Schutt T, Eckert A, Leuner K, MullerWE(2010) The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide. Br J Pharmacol 160, 246-257.
32. Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77, 1081-1132.
33. Chasseigneaux S, Allinquant B (2012) Functions of A, sAPP and sAPP: Similarities and differences. J Neurochem 120(Suppl), 99-108.
34. Agholme L, Lindström T, Kågedal K, Marcusson J, Hallbeck M(2010) An in vitro model for neuroscience: Differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis 20, 1069-1082.
35. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Dröse S, Brandt U, Savaskan E, Czech C, Götz J, Eckert A (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A 106, 20057-20062.
36. Lenaz G, Bovina C, Castelluccio C, Fato R, Formiggini G, Genova ML, Marchetti M, Pich MM, Pallotti F, Parenti Castelli G, Biagini G (1997) Mitochondrial complex I defects in aging. Mol Cell Biochem 174, 329-333.
37. Brinkley BR, Barham SS, Barranco SC, Fuller GM (1974) Rotenone inhibition of spindle microtubule assembly in mammalian cells. Exp Cell Res 85, 41-46.
38. Fang N, Casida JE (1998) Anticancer action of cubé insecticide: Correlation for rotenoid constituents between inhibition of NADH: Ubiquinone oxidoreductase and induced ornithine decarboxylase activities. Proc Natl Acad Sci U S A 95, 3380-3384.
39. Garcia J, Barluenga S, Gorska K, Sasse F, Winssinger N (2012) Synthesis of deguelin-biotin conjugates and investi gation into deguelin's interactions. Bioorg Med Chem 20, 672-680.
40. Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics. Nat Rev Drug Discov 10, 698-712.
41. Swerdlow RH, Burns JM, Khan SM (2013) The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim Biophys Acta, doi: 10.1016/j.bbadis. 2013.09.010
42. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
43. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7, 137-152.
44. Morley JE, Farr SA (2014) The role of amyloid-beta in the regulation of memory. Biochem Pharmacol 88, 479-485.
45. Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Götz J, Eckert A (2012) Insights into mitochondrial dysfunction: Aging, amyloid-, and tau-A deleterious trio. Antioxid Redox Signal 16, 1456-1466.
46. Hellström-Lindahl E, Ravid R, Nordberg A (2008) Agedependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with A beta levels. Neurobiol Aging 29, 210-221.
47. Hellström-Lindahl E, Viitanen M, Marutle A (2009) Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease. Neurochem Int 55, 243-252.
48. Morishima-Kawashima M, Oshima N, Ogata H, Yamaguchi H, Yoshimura M, Sugihara S, Ihara Y (2000) Effect of apolipoproteinEallele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am J Pathol 157, 2093-2099.
49. Funato H, Yoshimura M, Kusui K, Tamaoka A, Ishikawa K, Ohkoshi N, Namekata K, Okeda R, Ihara Y (1998) Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. Am J Pathol 152, 1633-1640.
50. Lesné SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH (2013) Brain amyloid- oligomers in ageing and Alzheimer's disease. Brain 136, 1383-1398.
51. Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE (2010) Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J Neuropathol Exp Neurol 69, 98-108.
52. Chiu C, Miller MC, Caralopoulos IN,Worden MS, Brinker T, Gordon ZN, Johanson CE, Silverberg GD (2012) Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months. Fluids Barriers CNS 9, 3.
53. Tillement L, Lecanu L, Papadopoulos V (2011) Alzheimer's disease: Effects of amyloid on mitochondria. Mitochondrion 11, 13-21.
54. Hauptmann S, Scherping I, Dröse S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Müller WE (2009) Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age inADtransgenic mice. Neurobiol Aging 30, 1574-1586.
55. Pagani L, Eckert A (2011) Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011, 925050.
56. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue L-F, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS,Wu H (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452.
57. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan S, Du (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14, 1097-1105.
58. Sirk D, Zhu Z, Wadia JS, Shulyakova N, Phan N, Fong J, Mills LR (2007) Chronic exposure to sub-lethal beta-amyloid (Abeta) inhibits the import of nuclear-encoded proteins to mitochondria in differentiated PC12 cells. J Neurochem 103, 1989-2003.
59. Demetrius LA, Simon DK (2012) An inverse-Warburg effect and the origin of Alzheimer's disease. Biogerontology 13, 583-594.
60. Butterfield DA, Hardas SS, Lange MLB (2010) Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: Many pathways to neurodegeneration. J Alzheimers Dis 20, 369-393.
61. Zhu X, Perry G, Smith MA, Wang X (2013) Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 33(Suppl 1), S253-S262.
62. Reddy PH (2009) Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol 218, 286-292.
63. Picard M, Shirihai OS, Gentil BJ, BurelleY(2013) Mitochondrial morphology transitions and functions: Implications for retrograde signaling?AmJ Physiol Regul IntegrCompPhysiol 304, R393-R406.
64. Eckmann J, Eckert SH, Leuner K, Muller WE, Eckert GP (2013) Mitochondria: Mitochondrial membranes in brain ageing and neurodegeneration. Int J Biochem Cell Biol 45, 76-80.
65. Stockburger C, Kurz C, Koch KA, Eckert SH, Leuner K, Müller WE (2013) Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam. Biochem Soc Trans 41, 1331-1334.
66. Lomoio S, López-González I, Aso E, Carmona M, Torrejón- Escribano B, Scherini E, Ferrer I (2012) Cerebellar amyloid- plaques: Disturbed cortical circuitry in APP/PS1 transgenic mice as a model of familial Alzheimer's disease. J Alzheimers Dis 31, 285-300.
67. Zheng H,Koo EH(2011) Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener 6, 27.
68. Gakhar-Koppole N, Hundeshagen P, Mandl C, Weyer SW, Allinquant B, Müller U, Ciccolini F (2008) Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway. Eur J Neurosci 28, 871-882.
69. Kögel D, Deller T, Behl C (2012) Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging. Exp Brain Res 217, 471-479.
70. Zhang Y, Chen Y, Liu Y, Zhao Y, Liao F-F, Xu H (2013) APP regulates NGF receptor trafficking and NGF-mediated neuronal differentiation and survival. PLoS One 8, e80571.